Cd. Helgason et al., OVEREXPRESSION OF HOXB4 ENHANCES THE HEMATOPOIETIC POTENTIAL OF EMBRYONIC STEM-CELLS DIFFERENTIATED IN-VITRO, Blood, 87(7), 1996, pp. 2740-2749
Little is known about the molecular mechanisms controlling primitive h
ematopoietic stem cells, especially during embryogenesis. Homeobox gen
es encode a family of transcription factors that have gained increasin
g attention as master regulators of developmental processes and recent
ly have been implicated in the differentiation and proliferation of he
matopoietic cells. Several Hox homeobox genes are now known to be diff
erentially expressed in various subpopulations of human hematopoietic
cells and one such gene, HOXB4, has recently been shown to positively
determine the proliferative potential of primitive murine bone marrow
cells, including cells with long-term repopulating ability. To determi
ne if this gene might influence hematopoiesis at the earliest stages o
f development, embryonic stem (ES) cells were genetically modified by
retroviral gene transfer to overexpress HOXB4 and the effect on their
in vitro differentiation was examined. HOXB4 overexpression significan
tly increased the number of progenitors of mixed erythroid/myeloid col
onies and definitive, but not primitive, erythroid colonies derived fr
om embryoid bodies (EBs) at various stages after induction of differen
tiation. There appeared to be no significant effect on the generation
of granulocytic or monocytic progenitors, nor on the efficiency of EB
formation or growth rate. Analysis of mRNA from EBs derived from HOXB4
-transduced ES cells on different days of primary differentiation show
ed a significant increase in adult beta-globin expression, with no det
ectable effect on GATA-1 or embryonic globin (beta H-1). Thus, HOXB4 e
nhances the erythropoietic, and possibly more primitive, hematopoietic
differentiative potential of ES cells. These results provide new evid
ence implicating Hox genes in the control of very early stages in the
development of the hematopoietic system and highlight the utility of t
he ES model for gaining insights into the molecular genetic regulation
of differentiation and proliferation events. (C) 1996 by The American
Society of Hematology.